Cyclicpeptide drug discovery Peptide drug discovery is experiencing a significant resurgence, driven by advancements in delivery systems, manufacturing, and computational methods like artificial intelligence. These therapeutic peptides, which are short chains of amino acids, are emerging as a powerful class of medicines capable of targeting diseases that challenge traditional modalities. The field has evolved considerably from its early focus on naturally occurring hormones, with researchers now employing sophisticated techniques to design and develop safe and effective peptide therapeutics. This growing interest is reflected in the increasing number of FDA-approved peptide drugs and those currently in clinical trials, underscoring the dynamic and promising future of peptide-based drug development.
Peptides, defined as short chains of amino acids with molecular weights typically between 500 and 5000 Daltons, have a rich history in medicine, with insulin being the first peptide drug introduced in 1922. However, early challenges such as proteolytic instability and poor bioavailability limited their widespread applicationCurrent challenges in peptide-based drug discovery. Recent breakthroughs have addressed these limitations, paving the way for a new era of peptide-based therapies.We have 3 strategies to discover and develop novel therapeutic agents: (1) Peptide and small molecule therapeutics, (2) peptide-drug conjugates (PDCs), and (3) ... Innovations in drug delivery systems, for instance, are crucial for ensuring that these molecules reach their intended targets effectively. Furthermore, advancements in peptide synthesis, including sophisticated peptide chemistry and the development of cyclic peptides, offer enhanced stability and improved pharmacological properties.
Several key trends and technologies are currently shaping the landscape of peptide drug discovery. The integration of artificial intelligence (AI) and machine learning (ML) is revolutionizing the process, enabling the development of predictive models for peptide design and optimization using complex datasets of protein sequences and structures. These computational tools accelerate the identification of promising peptide candidates, reducing the time and cost associated with traditional discovery methods作者：X Ji·2024·被引用次数：357—Cyclicpeptidescombine a number of favorable properties that make them attractive fordrug development. Today, more than 40 therapeutics ....
Beyond AI, novel wet-lab and computational multi-omic methods are providing deeper insights into peptide interactions and efficacy. Techniques such as peptide display technology, including mRNA display, are yielding better leads for peptide drug development.作者：K Fosgerau·2015·被引用次数：3719—We discuss thecurrent status, strengths, and weaknesses of peptides as medicinesand the emerging new opportunities in peptide drug design and development. The exploration of peptide-drug conjugates (PDCs) also represents a significant trend, combining the targeting capabilities of peptides with the potency of small molecules or cytotoxic agents to create highly specific and effective therapeutics.
Peptide-based drugs offer several advantages over conventional small molecule therapeutics. They often exhibit higher selectivity due to their specific interactions with biological targets, leading to potentially fewer off-target side effects.作者：K Fosgerau·2015·被引用次数：3719—We discuss thecurrent status, strengths, and weaknesses of peptides as medicinesand the emerging new opportunities in peptide drug design and development. Their ability to mimic natural hormones and peptides also makes them well-suited for targeting a wide range of diseasesPeptide therapeutics.
Despite these advantages, challenges persist in peptide drug developmentCreativePeptidesoffers world-class services in the chemical synthesis of a variety ofpeptidecompounds at competitive prices.. Proteolytic instability remains a concern, although strategies like cyclization and the development of non-natural amino acids are mitigating this issue.作者：M Muttenthaler·2021·被引用次数：1959—We summarizekey trends in peptide drug discoveryand development, covering the early efforts focused on human hormones, elegant medicinal chemistry and ... Overcoming the increased proteolytic instability compared to small molecules and monoclonal antibodies is a continuous area of research. Furthermore, optimizing delivery methods to ensure adequate absorption and distribution within the body is critical for therapeutic success作者：S Kulkarni—Thepeptide drug discoveryresurgence stems from stability, delivery, AI, and manufacturing advances.. Understanding the current status, strengths, and weaknesses of peptides as medicines is essential for navigating these challenges and unlocking their full therapeutic potential.
The future of peptide drug discovery appears exceptionally bright, with ongoing research focused on expanding the therapeutic applications of these versatile molecules. From treating metabolic disorders like diabetes and obesity with peptide hormone-derived analogs to developing novel treatments for cancer and other complex diseases, the potential is vastRecent Advances in Peptide Drug Discovery: Novel .... As researchers continue to refine synthesis processes, improve delivery systems, and leverage cutting-edge technologies like AI, peptide therapeutics are poised to play an increasingly vital role in the pharmaceutical armamentarium, offering hope for patients with unmet medical needs.
Join the newsletter to receive news, updates, new products and freebies in your inbox.